Cargando…
Cystatin C, a Controversial Biomarker in Hypothyroid Patients under Levothyroxine Therapy: THYRenal, a Pilot Cohort Observational Study
Background: Cystatin C (Cys-C) is recognized as one of the most reliable renal function parameters in the general population, although it might be biased by thyroid status. Herein, we tested Cys-C and conventional renal parameters in a cohort of hypothyroid patients treated with Levothyroxine. Metho...
Autores principales: | Greco, Marta, Foti, Daniela Patrizia, Aversa, Antonio, Fuiano, Giorgio, Brunetti, Antonio, Simeoni, Mariadelina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565550/ https://www.ncbi.nlm.nih.gov/pubmed/32933111 http://dx.doi.org/10.3390/jcm9092958 |
Ejemplares similares
-
Liver Stiffness in Obese Hypothyroid Patients Taking Levothyroxine
por: Pujia, Roberta, et al.
Publicado: (2022) -
Secondary Hyperparathyroidism and Hypertension: An Intriguing Couple
por: Simeoni, Mariadelina, et al.
Publicado: (2020) -
Current evidence on the use of anti-RAAS agents in congenital or acquired solitary kidney
por: Simeoni, Mariadelina, et al.
Publicado: (2017) -
Endothelial dysfunction in patients with subclinical hypothyroidism and the effects of treatment with levothyroxine
por: Niknam, Nasmi, et al.
Publicado: (2016) -
Comparative Effectiveness of Levothyroxine, Desiccated Thyroid Extract, and Levothyroxine+Liothyronine in Hypothyroidism
por: Shakir, Mohamed K M, et al.
Publicado: (2021)